LEMAITRE VASCULAR INC LMAT

NASDAQ Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$76.11
$75.67
$118.01
Market cap
$1.74B
P/E (GAAP, TTM)
27.58
P/E (operating)
33.39
Dividend yield
1.2%
Revenue growth YoY
11.3%
EPS growth YoY
-13.3%
ROIC
14.3%
Piotroski F-score
7

Three ways to read the P/E

P/E (GAAP, TTM)
27.58

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
30.20

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
33.39

After-tax operating income only: the core business.

P/E (excl. gains)
30.16

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) 9.6% 11.2%-1.6 pts 15.0%-5.4 pts
EPS growth YoY (qtr) 23.3% 41.7%-18.3 pts 15.4%+7.9 pts
Revenue growth (TTM) 11.8% 13.3%-1.4 pts 14.1%-2.3 pts
EPS growth (TTM) 39.5% 38.1%+1.4 pts 22.8%+16.8 pts
P/E (GAAP, TTM) 28.90 35.28-6.38 ——
P/E (operating) 36.34 42.19-5.85 ——
P/E (excl. gains) 32.82 38.11-5.29 ——
P/B 4.82 5.59-0.78 ——
ROIC 14.3% 14.3%0.0 pts 13.0%+1.3 pts
Net margin 23.1% 23.1%0.0 pts 20.0%+3.1 pts
Dividend yield 1.1% 0.9%+0.2 pts ——
EPS (TTM) 2.86 2.72+5.1% 2.05+39.5%
Price $82.65 $95.96-13.9% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $67.97M -3.4% 11.3% 0.65 -12.2% -13.3% 22.1%
Jun 30, 2026 $70.38M 5.8% 9.6% 0.74 8.8% 23.3% 24.2%
Mar 31, 2026 $66.55M 3.3% 11.2% 0.68 -1.4% 41.7% 23.6%
Dec 31, 2025 * $64.45M 5.6% 15.7% 0.69 -8.0% 43.8% 24.2%
Sep 30, 2025 $61.05M -5.0% 11.4% 0.75 25.0% 53.1% 28.4%
Jun 30, 2025 $64.23M 7.3% 15.0% 0.60 25.0% 15.4% 21.5%
Mar 31, 2025 $59.87M 7.5% 12.0% 0.48 0.0% 9.1% 18.4%
Dec 31, 2024 * $55.72M 1.6% 14.0% 0.48 -2.0% 26.3% 20.1%
Sep 30, 2024 $54.82M -1.8% 15.6% 0.49 -5.8% 48.5% 20.3%
Jun 30, 2024 $55.85M 4.4% 11.4% 0.52 18.2% 44.4% 21.2%
Mar 31, 2024 $53.48M 9.4% 13.6% 0.44 15.8% 63.0% 18.5%
Dec 31, 2023 $48.88M 3.1% 19.4% 0.38 15.2% 52.0% 17.3%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 17, 2026 Date of the latest closing price used.
Price $76.11 Latest closing price.
Market cap $1.74B Price × shares outstanding.
Enterprise value $1.71B Market cap + debt − cash: the price of the whole business.
Shares 22.88M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 30.20 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) 27.58 Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 33.39 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 30.36 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 30.16 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG 0.77 P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) 1.42 TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 3.3% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) 3.6% TTM EPS ÷ price.
P/B 4.43 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 6.98 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 6.47 Market cap ÷ revenue of the last four quarters.
P/FCF 23.39 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 21.87 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT 25.23 Enterprise value ÷ operating income.
EV/Sales 6.86 Enterprise value ÷ revenue.
Book value / share 17.20 Shareholders' equity ÷ shares.
FCF yield 4.3% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 2.28 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains $0 One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income $7.27M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $67.97M Revenue of the latest reported quarter.
Net income (qtr) $15.02M Net income of the latest reported quarter.
EPS (qtr) 0.65 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 11.3% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -3.4% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -13.3% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) -12.2% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -13.5% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) -11.9% Latest quarter net income vs the previous quarter.
Gross margin (qtr) 71.7% Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) 26.0% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 22.1% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $269.36M Revenue of the last four quarters.
Net income (TTM) $63.34M Net income of the last four quarters.
EPS (TTM) 2.76 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 11.8% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 19.5% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 18.7% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 1.2% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) $0.9500 Dividends per share paid over the last 12 months.
Payout ratio 37.7% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 24.3% Dividends ÷ free cash flow.
Dividend growth (1y) 25.0% Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) 19.3% Annualised dividend growth over 3 years.
Dividend CAGR (5y) 16.6% Annualised dividend growth over 5 years.
Payments (12m) 4 Number of dividend payments in the last 12 months.
Last ex-dividend date Aug 20, 2026 Most recent ex-dividend date.
Buyback yield 0.1% Share repurchases ÷ market cap.
Shareholder yield 1.4% Dividend yield + buyback yield.
Profitability
Gross margin 71.5% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 31.4% EBITDA ÷ revenue.
Operating margin 27.2% Operating income ÷ revenue.
Net margin 23.1% Net income ÷ revenue.
FCF margin 29.8% Free cash flow ÷ revenue.
ROE 14.7% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 9.4% Return on assets: net income ÷ total assets.
ROIC 14.3% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 13.5% Latest fiscal year revenue vs the year before.
Net income growth (annual) 31.1% Latest fiscal year net income vs the year before.
EPS growth (annual) 30.6% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 15.6% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) 39.4% Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 12.89 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 12.89 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.78 Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA 0.00 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA -0.36 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage 13.10 Operating income ÷ interest expense.
Earnings quality
FCF conversion 129.0% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -3.8% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 3.1% Share-based compensation ÷ revenue.
R&D % revenue 5.7% Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 23.2% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.41 Revenue ÷ total assets.
Days sales outstanding 49 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables 19 Average days to pay suppliers.
Trading & momentum
52-week high $118.01 Highest price in the last 52 weeks.
52-week low $75.67 Lowest price in the last 52 weeks.
From 52-week high -35.5% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 0.6% How far above the 52-week low the price is.
Avg volume (30d) 121.30K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $9.96M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 7 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 6.73 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $249.60M Revenue of the latest fiscal year.
Net income $57.73M Net income of the latest fiscal year.
Diluted EPS 2.52 Diluted earnings per share of the latest fiscal year.
EBITDA $78.33M Operating income + depreciation & amortization.
Free cash flow $74.47M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $28.24M Cash and equivalents.
Equity $393.52M Shareholders' equity.
Total assets $615.69M Total assets.